Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel VLA-4 antagonists prepared and evaluated at Novartis

Aug. 24, 1999

Neurokinin receptors with broad potential utility discovered at Schering-Plough

Aug. 20, 1999

SRL-172 shows promising initial results in phase I/II asthma trial

Aug. 20, 1999

Discovery receives Cystic Fibrosis Foundation grant for SuperVent

Aug. 20, 1999

Cell adhesion inhibitor series has potential application in inflammatory and immune disorders

Aug. 18, 1999

Immune Network Research forms JV with Bridge Pharma to develop asthma drug

Aug. 18, 1999

Antiinflammatory effects of TxA2 antagonist confirmed in patients with asthma

Aug. 13, 1999

Dual-action antihistamines/substance P antagonists from HMR

Aug. 12, 1999

Bayer will begin clinical trials of IL-4 antagonist for asthma

Aug. 12, 1999

Bayer reveals antiinflammatory PDE4 inhibitors in patent literature

Aug. 10, 1999

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...